2023 State Maternal Mental Health Legislation Report
In 2023, there was an uptick in the number of state legislatures...
Category: Report
Zurzuvae, the New Postpartum Depression Drug Now Available in the U.S. – This is How Insurers Have Responded
Zurzuvae™, the new first-of-its-kind 14-day postpartum depression pill, recently available in the...
A Comprehensive Look at State Maternal Mental Health Screening and Reimbursement Legislation
This report summarizes state legislative mandates addressing maternal mental health (MMH) screening...
2023 Annual Impact Report
This 2023 Impact Report highlights how the Policy Center continues to advance...
Maternal Mental Health Provider Shortages & Population Risk Report
The report illustrates where, in the U.S., mothers are at the greatest...
U.S. Maternal Depression Screening Rates Released for the First Time Through HEDIS
The first set of U.S. maternal depression screening data is now available...
10-15 of 15 Results
Load More Articles